Report Overview

Canadas Smart Inhalers market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of greater than xx% during the forecast period.

Inhalers are used for providing medication to the patients through the lungs. These are used for the treatment of the patient from asthma attacks and other respiratory ailments. As the prevalence of asthma and other diseases increases across Canada, the demand for inhalers is also expected to increase for treatment purposes. As of 2018, More than 3 million Canadians were suffering from asthma and this number is increasing significantly. mortalities related to asthma and COPD are high in Canada and due to these a significant investment by the government and people can be forecast in the near future.



Market Drivers

Increasing incidence of respiratory diseases, rising awareness, increase in the aging population, increasing investments are the major driving factors of this market. Other factors are the rise in air pollution, and growth in healthcare burden due to higher cases of asthma and COPD. The growing focus on the development of new devices in the medical sector is straight, and it is elevating the demand for the smart inhalers market. These devices are beneficial for physicians to track their patients inhale usage, which is additionally accelerating the growth rate of the market. The surge in the occurrence rate of COPD and cystic fibrosis is predicted to fuel market growth. The easy availability of the devices in pharmaceutical stores and online stores is expanding the size of the market. Smart inhalers are very accurate and promote the best treatment for patients who have asthma and chronic obstructive pulmonary diseases.